ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XERS Xeris Biopharma Holdings Inc

2.19
0.15 (7.35%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Xeris Biopharma Holdings Inc XERS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.15 7.35% 2.19 19:55:09
Open Price Low Price High Price Close Price Prev Close
2.13 2.11 2.2799 2.21 2.04
more quote information »

Recent News

Date Time Source Heading
3/06/202416:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/06/202416:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/06/202407:27EDGAR2Form 8-K - Current report
3/06/202407:02BWXeris Biopharma Reports Fourth Quarter and Full Year 2023..
3/06/202407:00BWXeris Refinances Its $150M Senior Secured Term Loan Facility..
2/28/202407:00BWXeris Biopharma to Report Fourth Quarter and Full Year 2023..
2/05/202407:00BWXeris to Present at the Oppenheimer 34th Annual Healthcare..
1/31/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/10/202410:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
1/10/202408:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
1/10/202408:00BWXeris Biopharma Enters Into an Exclusive Worldwide License..
1/05/202416:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
1/04/202407:09EDGAR2Form 8-K - Current report
1/04/202407:00BWXeris Biopharma Updates Its Outlook for 2023
12/27/202307:00BWXeris Biopharma to Present at the 42nd Annual J.P. Morgan..
11/21/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:20EDGAR2Form 8-K - Current report
11/09/202307:00BWXeris Biopharma Reports Third Quarter 2023 Financial Results
10/16/202307:12EDGAR2Form 8-K - Current report
10/16/202307:00BWXeris Biopharma Raises Full-Year Financial Guidance and..
9/29/202316:55EDGAR2Form 8-K - Current report
9/27/202308:11EDGAR2Form 8-K - Current report
9/27/202308:00BWXeris Biopharma Announces Private Convertible Note Exchange..
9/14/202316:05BWXeris to Participate in the 2023 Cantor Global Healthcare..
8/28/202307:00BWXeris to Participate at the H.C. Wainwright 25th Annual..
8/08/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:23EDGAR2Form 8-K - Current report
8/08/202307:00BWXeris Biopharma Reports Second Quarter 2023 Financial..
8/01/202307:00BWXeris Biopharma to Report Second Quarter 2023 Financial..
7/31/202307:00BWXeris Ships One Millionth Gvoke® Unit
6/28/202316:28EDGAR2Form 8-K - Current report
6/21/202307:00BWXeris Biopharma Announces First Participant Dosed in a Phase..
6/01/202307:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
5/09/202307:00BWXeris Biopharma Reports First Quarter 2023 Financial Results
5/02/202307:00BWXeris Biopharma to Report First Quarter 2023 Financial..
4/18/202307:00BWXeris Biopharma Announces Issuance of U.S. Patent Covering..
3/30/202307:00BWXeris Biopharma Announces Research Evaluation Collaboration..

Your Recent History

Delayed Upgrade Clock